Dr. Rajeeve Kumar Rajput

Consultant

36 Years of Experience

Interventional Cardiologist

MBBS, MD, DM, FICC, FIMSA, FSCAI, FESC

Indraprastha Apollo Hospital, New Delhi

English

Consultation Fee ₹ 1500

Book an Appointment

About Dr. Rajeeve Kumar Rajput

Dr. Rajeev Kumar Rajput is a distinguished Interventional Cardiologist with over 30 years of experience.
He specializes in the treatment of heart attack, heart failure, and high blood pressure.
He also has expertise in angioplasty, stenting, and pacemaker implantation.
After completing his MBBS from the University of Lucknow in 1988, he also achieved a DM in cardiology in 1994 and an MD in general medicine from the University of Lucknow in 1991.
Dr. Rajeeve has received training from prestigious institutions in India and abroad, earning high praise from his patients for his exceptional cardiac care.
He has authored numerous research studies over his extensive career, making significant contributions to the field of cardiology and interventional cardiology.
He is an esteemed member of the Cardiological Society of India, the Indian Medical Association (IMA), and the National Interventional Council.

Education

MBBS, University of Lucknow, 1988
MD (General Medicine), University of Lucknow, 1991
DM (Cardiology), University of Lucknow, 1994
Fellowship of Indian College of Cardiology, 2007
Fellowship of International Medical Society of India, 2007
Fellowship of the College of the Asian Pacific Society of Cardiology, 2007
Fellowship of Society of Cardiac Angiography and Intervention, 2010
Fellowship of European Society Of Cardiology, 2015

Past Experience

King George's Medical College, Lucknow, UP, India, 1982 - 1987
Clinical Internship, King George's Medical College, Lucknow, UP, India, 1987 - 1988
House Officer, George's Medical College. Lucknow, UP, India, 1988 - 1989
Medical Resident, King George's Medical College, Lucknow, UP, India, 1989 - 1991
Chief Resident, KG Medical College, Lucknow, UP, India, 1991 - 1992
Registrar, KG Medical College.Lucknow, UP, India, 1992 - 1996
Senior Research Associate, KG Medical College, Lucknow, UP, India, 1996 - 1997
Clinical Fellow in Interventional Cardiology, St Vincent's Hospital, Victoria Street, Darlinghurst, Sydney, Australia, 1997 - 1998
Clinical fellow in Heart Failure and Transplant Unit, St. Vincent's Hospital, Victoria Street, Darlinghurst Sydney, Australia, 1998 - 1999
Clinical Fellow, National Heart Center Singapore, 1999 - 1999
Senior Consultant, Apollo Hospital, New Delhi, 1999 - Present
Senior Consultant, Heart & Gynae Clinic

Awards

Distinguished Service Award

Paper Published

New Balloon Expandable Stent For Furcation Coronary Lesions Letter To The Editor Catheter And Cardiovascular Diagnosis 1997 42-2-235-6.
Improvement In Contractility Of Infarcted Segment After Dobutamine Infusion Correlated With Good (TIMI 2-3 Flow In Infarct Related Artery; Indian Heart Journal 1997 March).
Dobutamine Induced Distant Wall Motion Abnormalities After Acute Myocardial Infarction Predict Multivessel Coronary Artery Disease; Indian Heart Journal 1995; 47; 349-5.
Role Of Metoprolol On Left Ventricular Remodelling Early After Acute Myocardial Infarction; Indian Heart Journal 1995 Abstract 230.
True Restenosis After Balloon Mitral Valvuloplasty; Indian Heart Journal 1995 Abstract 111.
Serum And Platelet Sialic Acid In Acute Myocardial Infarction; Indian Heart Journal 1995 Abstract 97.
Mitral Valve Reserve Capacity; The True Measure Of Successful Mitral Valvuloplasty; Indian Heart Journal; Abstract 1997
Significance Of Lipoprotein A In Coronary Artery Syndromes; Indian Heart Journal 1995 Abstract 242.
MD Project Bone Marrow Culture Studies In Patients Of Leukemias 1991, Lucknow University.
DM Project Dobutamine Stress Echocardiography In Early Post MI Phase It's Predictive Valve To Diagnose Multivessel Coronary Artery Disease 1995.
Immediate And Short Term Results Of Treating Bifurcation Coronary Lesions With A New Side Branch Stent; Annual Australian Cardiac Society Meeting 1998 73 65.
Time Course Of Reverse Left Ventricular Remodelling In Response To Carvedilol In Heart Failure Australian Cardiac Society Meeting 1998 84 68.